FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves Chartwell RX, LLC's supplemental application for rifampin (RIFAMPIN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Meningococcal Disease
• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)